Literature DB >> 22240442

The interaction between prorenin, renin and the (pro)renin receptor: time to rethink the role in hypertension.

Timothy L Reudelhuber1.   

Abstract

PURPOSE OF REVIEW: Elevated prorenin levels are seen in diabetics with microvascular disease. The discovery of a receptor capable of binding renin and prorenin [(P)RR] and triggering an intracellular signal in the laboratory setting raised the expectation that prorenin might be directly responsible for these vascular disorders. However, there has been substantial disagreement concerning the signaling properties of renin and prorenin and it has been impossible to inactivate the (P)RR gene in mouse to define its function. RECENT
FINDINGS: Mouse and rat models in which prorenin is highly overexpressed do not demonstrate the glomerulosclerosis typically seen in severe diabetic nephropathy, but do exhibit an increase in blood pressure that is angiotensin II-dependent. (P)RR has been shown to colocalize with other subunits of the vacuolar ATPase in the kidney and heart and to be necessary for Wnt signaling in a renin-independent manner. Although whole-body inactivation of the (P)RR gene is lethal, tissue-specific inactivation results in severe disorders associated with massive cell death.
SUMMARY: These results do not support a role of direct prorenin or renin signaling through (P)RR in vascular disorders. Rather, they suggest that the main role of (P)RR is as a subunit of the vacuolarATPase complex. Whether or not (P)RR is responsible for the ability of prorenin to generate angiotensin II in tissues has not been resolved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240442     DOI: 10.1097/MNH.0b013e3283500927

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  5 in total

1.  Increased expression of (pro)renin receptor does not cause hypertension or cardiac and renal fibrosis in mice.

Authors:  Alva Rosendahl; Gianina Niemann; Sascha Lange; Erfan Ahadzadeh; Christian Krebs; Aurelie Contrepas; Harry van Goor; Thorsten Wiech; Michael Bader; Michael Schwake; Judith Peters; Rolf Stahl; Geneviève Nguyen; Ulrich O Wenzel
Journal:  Lab Invest       Date:  2014-07-21       Impact factor: 5.662

2.  Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice.

Authors:  Chia-Hua Wu; Shayan Mohammadmoradi; Joel Thompson; Wen Su; Ming Gong; Genevieve Nguyen; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

3.  Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.

Authors:  Nilima Biswas; Adam X Maihofer; Saiful Anam Mir; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Manjula Mahata; Ryan S Friese; C Makena Hightower; Sushil K Mahata; Dewleen G Baker; Caroline M Nievergelt; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  BMC Med Genet       Date:  2016-03-11       Impact factor: 2.103

Review 4.  New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.

Authors:  Jia L Zhuo; Fernanda M Ferrao; Yun Zheng; Xiao C Li
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-11       Impact factor: 5.555

5.  The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.

Authors:  Sebastian Kirsch; Eva Schrezenmeier; Sabrina Klare; Daniela Zaade; Kerstin Seidel; Jennifer Schmitz; Sarah Bernhard; Dilyara Lauer; Mark Slack; Petra Goldin-Lang; Thomas Unger; Frank S Zollmann; Heiko Funke-Kaiser
Journal:  Int J Mol Med       Date:  2014-01-14       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.